logo 2

Inscopix is a neurotechology company developing preclinical solutions for real-time brain mapping to drive new treatments designed to improve the health and well-being of people suffering from debilitating brain disorders. Inscopix’s flagship miniscope systems have been deployed in over 500 research institutions worldwide resulting in over 170 top-tier scientific publications.

As many brain disorders are understood to be a dysregulation of neural circuits, biopharma is harnessing the Inscopix neural circuit platform for an end-to-end, data-driven method to de-risk neurotherapeutic preclinical drug development. Key areas of focus range from circuit-based pharmacodynamics and dose-finding to efficacy and disease areas span from Alzheimer’s, Parkinson’s, chronic pain, addiction to psychiatric disorders.

Based in the heart of Silicon Valley, our team brings together deep domain expertise in neuroscience, engineering, and data science. We are committed to partnering with you on the next generation of neurotherapeutics to improve brain health.

Team Members


Jonathan Nassi

Senior Director, Translational Science


Basile Siewe

Senior Director, Business Development - Global Biopharma